Riise T, Grønning M, Aarli J A, Nyland H, Larsen J P, Edland A
Section for Medical Informatics and Statistics, University of Bergen, Haukeland Hospital, Norway.
J Clin Epidemiol. 1988;41(10):1031-6. doi: 10.1016/0895-4356(88)90041-8.
To determine if such factors as first symptom, sex, age at onset and initial clinical course have any influence on life expectancy of multiple sclerosis patients, a survival analysis from date of diagnosis for 598 MS-patients in Norway was performed. To study the effect of all the variables simultaneously we used the Cox proportional hazards regression model with incomplete data. Median survival time was 27 years after diagnosis. The variable which most strongly predicted the duration of the disease was age at onset. High age at onset and a progressive course of the disease were correlated with a more unfavourable prognosis. The onset symptom, vertigo, was also correlated with a shorter life expectancy. No significant effect of sex was found. We found in this material an indication of improved survival over the study period.
为了确定首发症状、性别、发病年龄和初始临床病程等因素是否对多发性硬化症患者的预期寿命有任何影响,我们对挪威598例多发性硬化症患者从诊断之日起进行了生存分析。为了同时研究所有变量的影响,我们使用了具有不完全数据的Cox比例风险回归模型。诊断后的中位生存时间为27年。最能强烈预测疾病持续时间的变量是发病年龄。发病年龄较大和疾病呈进行性病程与更不利的预后相关。首发症状眩晕也与较短的预期寿命相关。未发现性别有显著影响。我们在该研究资料中发现了在研究期间生存率有所提高的迹象。